← Leaderboards
Matthew R Allen
Rlr Va Medical Center
$4,949,850
Attributed
$8,425,874
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,425,874 · 7
VA$0 · 2
By mechanism
R01$7,499,429 · 4
R21$422,345 · 1
P30$270,100 · 1
R25$234,000 · 1
I01$0 · 1
IK6$0 · 1
Top collaborators
- Sharon M Moe10 shared
- Thomas L. Nickolas8 shared
- Joseph Michael Wallace2 shared
- Sylk Sotto1 shared
Most similar at Rlr Va Medical Center
Same institution · by research overlap
- Joseph Michael Wallace$3,017,414
Others in their field
Top investigators on “Bone”
- David Heimbrook · Leidos Biomedical Research, Inc.$240,577,094
- Charles A Coltman · Southwest Oncology Group$141,983,231
- Mary M Horowitz · Medical College Of Wisconsin$136,789,389
- Gregory D Peterson · University Of Tennessee Knoxville$84,527,696
- Richard A Gibbs · Baylor College Of Medicine$64,141,825
- Jeffrey Krischer · University Of South Florida$61,545,982
Research focus
BoneMechanicsFractureTissuesSkeletalAffectPropertyChronic Kidney FailureAnimalsOsteoporosisBone QualityRattusClinicAnimal ModelMineralsDoseBisphosphonateIn VivoKidney DiseasesFda ApprovedExperimental StudyCollagenFracture RiskBone Mass
Grant awards (35)
Uremic toxins and osteocyte dysfunction in CKD$550,066
R01 · FY2025 · DK
Precision medicine approaches to renal osteodystrophy$500,152
R01 · FY2025 · DK
Histology and Histomorphometry Core (HHC)$127,943
P30 · FY2025 · AR · contact PI
Clinical and Translational Science Workforce Development through a Statewide Community College Partnership$108,000
R25 · FY2025 · TR · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
Uremic toxins and osteocyte dysfunction in CKD$598,846
R01 · FY2024 · DK
Precision medicine approaches to renal osteodystrophy$517,994
R01 · FY2024 · DK
Histology and Histomorphometry Core (HHC)$142,157
P30 · FY2024 · AR · contact PI
Clinical and Translational Science Workforce Development through a Statewide Community College Partnership$18,000
R25 · FY2024 · TR · contact PI
Treating bone deterioration associated with chronic kidney disease$0
I01 · FY2024 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2024 · VA · contact PI
Precision medicine approaches to renal osteodystrophy$550,039
R01 · FY2023 · DK
Clinical and Translational Science Workforce Development through a Statewide Community College Partnership$108,000
R25 · FY2023 · TR · contact PI
Treating bone deterioration associated with chronic kidney disease$0
I01 · FY2023 · VA · contact PI
Precision medicine approaches to renal osteodystrophy$581,086
R01 · FY2022 · DK
Treating bone deterioration associated with chronic kidney disease$0
I01 · FY2022 · VA · contact PI
Treating bone deterioration associated with chronic kidney disease$0
I01 · FY2021 · VA · contact PI
Pathogenesis of compromised bone quality and mechanics in chronic kidney disease.$431,326
R01 · FY2019 · DK
Treating bone deterioration associated with chronic kidney disease$0
I01 · FY2019 · VA · contact PI
Pathogenesis of compromised bone quality and mechanics in chronic kidney disease.$461,139
R01 · FY2018 · DK
Treating bone deterioration associated with chronic kidney disease$0
I01 · FY2018 · VA · contact PI
Pathogenesis of compromised bone quality and mechanics in chronic kidney disease.$470,578
R01 · FY2017 · DK
Treating bone deterioration associated with chronic kidney disease$0
I01 · FY2017 · VA · contact PI
Pathogenesis of compromised bone quality and mechanics in chronic kidney disease.$471,810
R01 · FY2016 · DK
Enhancing bone strength using combination drug therapy$322,702
R01 · FY2016 · AR · contact PI
Treating bone deterioration associated with chronic kidney disease$0
I01 · FY2016 · VA · contact PI
Enhancing bone strength using combination drug therapy$499,103
R01 · FY2015 · AR · contact PI
Enhancing bone strength using combination drug therapy$450,706
R01 · FY2014 · AR · contact PI
Enhancing bone strength using combination drug therapy$38,958
R01 · FY2014 · AR · contact PI
Enhancing bone strength using combination drug therapy$441,711
R01 · FY2013 · AR · contact PI
Enhancing bone strength using combination drug therapy$154,928
R01 · FY2013 · AR · contact PI
Enhancing bone strength using combination drug therapy$458,285
R01 · FY2012 · AR · contact PI
Bisphosphonate-related osteonecrosis of the jaw: Bridging the clinical-preclinica$114,345
R21 · FY2010 · DE · contact PI
Bisphosphonate-related osteonecrosis of the jaw: Bridging the clinical-preclinica$308,000
R21 · FY2009 · DE · contact PI